PetVivo’s Regenerative Medicine Strategy Takes a Major Step Forward

Jun 30, 2026

👉 Watch the full interview here:

PetVivo CEO John Lai discusses the company’s acquisition of PZO Bio and how combining proprietary nanofiber technology with the SPRYNG™ platform could expand regenerative medicine applications across veterinary healthcare and future human medical markets.

Watch the full interview to learn more about PetVivo’s technology platform, product development strategy, and long-term vision for regenerative medicine.

#PetVivo #Biotechnology #RegenerativeMedicine #MedTech #HealthcareInnovation #Investing #BusinessNews #BiotechStocks #GrowthStocks #VeterinaryMedicine #LifeSciences #MedicalTechnology #Innovation #NASDAQ #Healthcare

PetVivo’s Regenerative Medicine Strategy Takes a Major Step Forward

Recommended

Lakosky Brookman Managing Partner: How Microcap Companies Get Listed and Stay Listed

HPB CEO: Solid-State Battery Technology Targets U.S. Data Centers Through BastionVolt

Dr. Kellie Gurley Explains Why AI Initiatives Fail and How Companies Can Succeed

FreeCast Launches Sports Hub to Help Fans Find Where to Watch Live Games

YY Force Opens Singapore Robotics Center to Train Humanoid Robots for Real-World Jobs

American Fusion Chairman: Texatron Fusion Could Power Data Centers Without Nuclear Waste

PetVivo’s Regenerative Medicine Strategy Takes a Major Step Forward

Recommended

Lakosky Brookman Managing Partner: How Microcap Companies Get Listed and Stay Listed

HPB CEO: Solid-State Battery Technology Targets U.S. Data Centers Through BastionVolt

Dr. Kellie Gurley Explains Why AI Initiatives Fail and How Companies Can Succeed

FreeCast Launches Sports Hub to Help Fans Find Where to Watch Live Games

YY Force Opens Singapore Robotics Center to Train Humanoid Robots for Real-World Jobs

American Fusion Chairman: Texatron Fusion Could Power Data Centers Without Nuclear Waste

Share

Investor Accreditation

For Individuals

Thank You!